Côte d'Ivoire vs Eritrea: Previously treated cases tested for RR-/MDR-TB
Côte d'Ivoire
100.0%
in 2024
Eritrea
100.0%
in 2024
Côte d'Ivoire rank
1st
Eritrea rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Côte d'Ivoire
- Eritrea
How they compare
Côte d'Ivoire currently reports 100.0% against 100.0% in Eritrea, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2013 it was Côte d'Ivoire ahead.
Côte d'Ivoire ranks 1st and Eritrea ranks 1st of 180 countries.
Across the 2 decades both report, Côte d'Ivoire averaged higher in 1 and Eritrea in 1.
Head to head by decade
| Decade | Côte d'Ivoire | Eritrea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 92.4% | 50.8% | 41.6% | Côte d'Ivoire |
| 2020s | 98.4% | 100.0% | 1.6% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Côte d'Ivoire or Eritrea?
- Côte d'Ivoire, at 100.0% against 100.0% in Eritrea as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Côte d'Ivoire and Eritrea?
- 0.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Eritrea?
- 10 years are reported by both, from 2013 to 2024.
- How do Côte d'Ivoire and Eritrea rank globally for previously treated cases tested for rr-/mdr-tb?
- Côte d'Ivoire ranks 1st and Eritrea ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.